Long-Term Outcome of Adult Acute Leukemia Patients Who Are Alive and Well Two Years After Allogeneic Bone Marrow Transplantation from an HLA-Identical Sibling

References

• Powles R, Mehta J, Singhal S, et al. Autologous bone marrow or peripheral blood stem cell transplantation followed by maintenance chemotherapy for adult acute lympho-blastic leukemia in first remission: 50 cases from a single center. Bone Marrow Transplant 1995; 16: 241–247
   PubMed Web of Science ®Google Scholar
• Mehta J, Powles R, Singhal S, et al. Autologous bone marrow transplantation for acute myeloid leukemia in first remission: identification of modifiable prognostic factors. Bone Marrow Transplant 1995; 16: 499–506
   PubMed Web of Science ®Google Scholar
• Mehta J, Powles R, Treleaven J, et al. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine. Bone Marrow Transplant 1996; 18: 741–746
   PubMed Web of Science ®Google Scholar
• Singhal S, Powles R, Treleaven J, Kulkami S, Horton C, Mehta J. Long-term outcome of adult acute leukemia patients who are alive and well two years after autologous blood or marrow transplantation. Bone Marrow Transplant, Submitted).
   Google Scholar
• Bearman SI, Appelbaum FR, Buckner CD, et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J. Clin. Oncol. 1988; 6: 1562–1568
   PubMed Web of Science ®Google Scholar
• Hjiyannakis P, Mehta J, Milan S, Powles R, Hinson J, Tait D. Melphalan, single-fraction total-body irradiation and allogeneic bone marrow transplantation for acute leukaemia: review of transplant-related mortality. Leuk. Lymphoma 1997; 25: 565–572
   PubMed Web of Science ®Google Scholar
• Rege K, Mehta J, Treleaven J, et al. Fatal pneumococ-cal infections following allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14: 903–906
   PubMed Web of Science ®Google Scholar
• Curtis RE, Rowlings PA, Deeg HJ, et al. Solid cancers after bone marrow transplantation. N. Engl. J.M ed. 1997; 336: 897–904
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Powles R, Singhal S, et al. Second cancers after non-autologous bone marrow transplantation for hematologic malignancies: single-center experience of 883 patients. Blood 1997; 90(Suppl 1)376, a.
   Google Scholar
• Powles R, Milan S, Horton C, Singhal S, Treleaven J, Mehta J. A prospective haemato-oncology patient database: Structure and description. Bone Marrow Transplant 1996; 17(Suppl 1), S140.
   Google Scholar
• Powles R, Milan S, Horton C, Singhal S, Treleaven J, Mehta J. A prospective haemato-oncology patient database for use in routine care and clinical research. Bone Marrow Transplant 1996; 17(Suppl 1), S55.
   Google Scholar
• Mehta J, Powles R, Treleaven J, et al. Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy. Bone Marrow Transplant 1997; 19: 709–719
   PubMed Web of Science ®Google Scholar
• Mehta J, Powles R, Singhal S, Horton C, Treleaven J. Outcome of autologous rescue after failed engraftment of allogeneic marrow. Bone Marrow Transplant 1996; 17: 213–217
   PubMed Web of Science ®Google Scholar
• Mehta J, Powles R, Horton C, et al. Bone marrow transplantation for primary refractory acute leukaemia. Bone Marrow Transplant 1994; 14: 415–418
   PubMed Web of Science ®Google Scholar
• Mehta J, Powles RL, Mitchell P, Rege K, De Lord C, Treleaven J. Graft failure after bone marrow transplantation from unrelated donors using busulphan and cyclophosphamide for conditioning. Bone Marrow Transplant 1994; 13: 583–587
   PubMed Web of Science ®Google Scholar
• Singhal S, Powles R, Treleaven J, Horton C, Mehta J. Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: alloengraftment with potential preservation of fertility. Bone Marrow Transplant 1996; 18: 1049–1055
   PubMed Web of Science ®Google Scholar
• Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation. 1974; 18: 295–304
   PubMed Web of Science ®Google Scholar
• Sullivan KM, Witherspoon RP, Storb R, et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood 1988; 72: 555–561
   PubMed Web of Science ®Google Scholar
• Singhal S, Powles R, Treleaven J, Rattenbury H, Mehta J. Pilocarpine hydrochloride for symptomatic relief of xerostomia due to chronic graft-versus-host disease or total-body irradiation after bone-marrow transplantation for hematologic malignancies. Leuk. Lymphoma 1997; 24: 539–543
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Powles R, Mehta J, et al. Thalidomide is very effective for chronic GVHD but has no activity in acute GVHD. Blood 1997; 90(Suppl l)376, a.
   Google Scholar
• Mehta J, Powles R, Horton C, Milan S, Singhal S, Treleaven J. The relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings. Bone Marrow Transplant 1995; 15: 853–858
   PubMed Web of Science ®Google Scholar
• Mehta J, Powles R, Treleaven J, Kulkarni S, Horton C, Singhal S. Number of nucleated cells infused during allogeneic and autologous bone marrow transplantation: an important modifiable factor influencing outcome. Blood 1997; 90: 3808–3810
   PubMed Web of Science ®Google Scholar
• Mehta J, Powles R, Treleaven J, Kulkami S, Singhai S. Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patients. Bone Marrow Transplant 1997; 20: 129–135
   PubMed Web of Science ®Google Scholar
• Singhal S, Powles R, Kulkarni S, Treleaven J, Saso R, Mehta J. Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-ver-sus-leukemia, and the problem of extramedullary relapse. Leuk. Lymphoma, In press).
   Web of Science ®Google Scholar
• Frassoni F, Labopin M, Gluckrnan E, et al. Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Leukemia 1994; 8: 924–928
   PubMed Web of Science ®Google Scholar
• Baker F, Wingard JR, Curbow B, et al. Quality of life of bone marrow transplant long-term survivors. Bone Marrow Transplant 1994; 13: 589–596
   PubMed Web of Science ®Google Scholar
• Bush NE, Haberman M, Donaldson G, Sullivan KM. Quality of life of 125 adults surviving 6–18 years after bone marrow transplantation. Soc. Sci. Med. 1995; 40: 479–490
   PubMed Web of Science ®Google Scholar
• Prieto JM, Saez R, Cameras E, et al. Physical and psychosocial functioning of 117 survivors of bone marrow transplantation. Bone Marrow Transplant 1996; 17: 1133–1142
   PubMed Web of Science ®Google Scholar
• Gore EM, Lawton CA, Ash RC, Lipchik RJ. Pulmonary function changes in long-term survivors of bone marrow transplantation. Int. J. Radiat. Oncol. Biol. Phys. 1996; 36: 67–75
   PubMed Web of Science ®Google Scholar
• Forsyth CJ, Cremer PD, Torzillo P, Iland HJ, Young GA. Thalidomide responsive chronic pulmonary GVHD. Bone Marrow Transplant 1996; 17: 291–293
   PubMed Web of Science ®Google Scholar
• Hoyle C, Goldman JM. Life-threatening infections occurring more than 3 months after BMT. Bone Marrow Transplant 1994; 14: 247–252
   PubMed Web of Science ®Google Scholar
• Mehta J, Powles R, Singhal S, Riley U, Treleaven J, Catovsky D. Antimicrobial prophylaxis to prevent opportunistic infections in patients with chronic lymphocytic leukemia after allogeneic blood or marrow transplantation. Leuk. Lymphoma 1997; 26: 83–88
   PubMed Web of Science ®Google Scholar
• Singhal S, Mehta J. The Clinical Practice of Stem Cell Transplantation. Reimmunisation after transplantation, J Barrett, JG Treleaven. Isis Medical Media, Oxford 1998; 745–756
   Google Scholar
• Deeg HJ, Socie G. Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood 1998; 91: 1833–1844
   PubMed Web of Science ®Google Scholar
• Glynne P, Powles R, Steele J, et al. Renal dysfunction following autologous bone marrow transplantation in adult patients with acute leukemia. Acta Uncol. 1996; 35: 709–712
   PubMed Web of Science ®Google Scholar
• Powles RL, Barrett AJ, Clink H, Kay HE, Sloane J, McE1-Wain TJ. Cyclosporin A for the treatment of graft-ver-sus-host disease in man. Lancet 1978; 2: 1327–1331
   PubMed Web of Science ®Google Scholar
• Powles RL, Clink HM, Spence D, et al. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet 1980; 1: 327–329
   PubMed Web of Science ®Google Scholar